Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joanna S. Yi
Observed names:
Joanna S Yi,
Joanna Yi
Institutions:
Baylor College of Medicine,
Texas Children's Hospital,
Dan L Duncan Comprehensive Cancer Center
Observed institutions:
Boston Children's Hospital,
Baylor College of Medicine,
Dana-Farber Cancer Institute,
Texas Children's Hospital,
Dana-Farber/Boston Children's Cancer and Blood Disorders Center,
Dan L Duncan Comprehensive Cancer Center
show all 6
ORCID:
0000-0002-0914-8728
Observed ORCID:
0000-0002-0914-8728
OpenAlex ID:
A5123575270
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621
2022
·
Maureen M. O'Brien
, Lingyun Ji
, et al.
·
Journal of Clinical Oncology
·
165
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C
2023
·
Susan N Chi
, Joanna S Yi
, et al.
·
JNCI Journal of the National Cancer Institute
·
119
PDF
Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience
2023
·
Adriana Trabal
, Amber Gibson
, et al.
·
Cancers
·
40
PDF
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53
2021
·
Joanna S. Yi
, Oscar Sias-Garcia
, et al.
·
Neoplasia
·
15
Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency
2021
·
Monika W. Perez
, Oscar Sias-Garcia
, et al.
·
Blood Advances
·
11
EZH2-driven immune evasion at disease presentation defines high-risk t(16;21) FUS::ERG pediatric AML
2026
·
Nathaniel J Buteyn
, Samantha J LaMantia
, et al.
·
Blood Neoplasia
·
7
PDF
Paediatric Therapeutic Development Workshop on rhabdoid tumours
2026
·
Claudia Montiel Equihua
, Jan J. Molenaar
, et al.
·
British Journal of Cancer
·
6
PDF
FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML
2025
·
Reeja Raj
, Samanta Catueno
, et al.
·
Blood
·
6
An analysis of diagnostic metabolomic profiles associated with hepatotoxicity during childhood ALL induction therapy
2025
·
Emily J. Mason
, Anna M. Crain
, et al.
·
Blood Advances
·
3
PDF
Epigenetic crosstalk in neuroblastoma development and progression
2026
·
Nathan Drolet
, Amber Wolf
, et al.
·
Frontiers in Cell and Developmental Biology
·
2
PDF
Sustained Response to Pan-BRAF Inhibitor Plixorafenib (FORE8394, PLX8394) in a Young Adult With Neurodegenerative Langerhans Cell Histiocytosis
2025
·
Joanna S. Yi
, Kathleen S. McCarthy
, et al.
·
JCO Precision Oncology
·
2
Acute Leukemia in the Crosshairs: First‐in‐Class Menin Inhibitor Approval for Adults and Children
2025
·
Joanna S. Yi
, Branko Cuglievan
·
Pediatric Blood & Cancer
·
2
Lipidomic profiles associated with treatment related hepatotoxicity in children with acute lymphoblastic leukemia
2026
·
Emily J. Mason
, Jeremy M. Schraw
, et al.
·
Supportive Care in Cancer
·
1
PDF
Incidence and outcomes of treatment-associated hepatotoxicity during pediatric acute lymphoblastic leukemia induction therapy: a Reducing Ethnic Disparities in Acute Leukemia (REDIAL) Consortium report
2026
·
Ashley N. Chavana
, Emily J. Mason
, et al.
·
Haematologica
·
1
PDF
Abstract A181: Transaminitis during induction is associated with subsequent methotrexate neurotoxicity in children with acute lymphoblastic leukemia: A report from the Reducing Disparities in Acute Leukemia (REDIAL) Consortium
2026
·
Emily J. Mason
, Olga A. Taylor
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
Characterization of chemoresistant cell populations improves risk stratification and therapy prediction in pediatric acute myeloid leukemia
2026
·
Mohammad Javad NajafPanah
, Alexandra M. Stevens
, et al.
·
Nature Communications
PDF
Diagnostic BMI and Induction Therapy Weight Change Associated With Hepatotoxicity in Pediatric Patients With Acute Lymphoblastic Leukemia
2026
·
Emily J. Mason
, John P. Woodhouse
, et al.
·
Cancer Medicine
PDF
CAMKV kinase drives neuroblastoma growth and acts as a novel therapeutic target
2026
·
Yang Yu
, Yanling Zhao
, et al.
·
The Journal of Experimental Medicine
PDF
Recurrent Hypoglycemia Following Asparaginase Therapy for Lymphoid Malignancies in Childhood: The Texas Children's Hospital Experience
2026
·
Manal Y. Tantoush
, Alfonso Hoyos‐Martinez
, et al.
·
Pediatric Blood & Cancer
Results of a phase II trial of nivolumab and ipilimumab in children and young adults with relapsed or refractory INI1-deficient cancers.
2026
·
Suzanne J. Forrest
, Thomas Cash
, et al.
·
Journal of Clinical Oncology
Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consortium
2026
·
Emily J. Mason
, John P. Woodhouse
, et al.
·
Pediatric Blood & Cancer
Show more works
View as search
Works count:
21
Citation count:
379
H-index:
6
I10-index:
5
Year
Topic
Type